Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial
Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial
A. Subbarao, Praveen Kumar Marimuthu, Sharief K Sidhique, A. Joel et al.
Journal
The Lancet Regional Health - Southeast Asia
Topics
Head and Neck Cancer Studies
article
Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial
A. Subbarao, Praveen Kumar Marimuthu, Sharief K Sidhique, A. Joel, Kovilapu Harikrishna, Jansi Rani, Simon Pavamani, Divya Bala Thumaty, Rajesh Isiah, Manu Mathew, Jino Victor Wilson, Deepa Susan Joy Philip, Chitra Renukaradhya, J. Riju, A. O. John, A. Tirkey, M. Thomas, B. K. Sasidharan, S. Sahu, J. T. Georgy, Rajiv C. Michael, Konduru Vidya, Mansi Agrawal, Ashish Singh
article en
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - Southeast AsiaVol. 47